Mapping large numbers of results may take a few moments.
Search Results
Showing 451 - 472 of 472 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company Velo Bio LLC | Activity: Research and Development | Company Description Velo Bio is developing an orphan drug for the treatment of severe preeclampsia in pregnant women. | Location Morrisville |
| |
Company Verb Biotics LLC | Activity: Research and Development | Company Description Verb Biotics identifies and designs new strains of probiotics and postbiotics for nutrition, health and wellness. | Location Durham |
| |
Company Verenovo Energy | Activity: Production and Manufacturing | Company Description Verenovo produces eco-friendly organic soil amendment products such as biochar and bio-fertilizers. Through their process, they also generate carbon off-set credits. | Location North Wilkesboro |
| |
Company Verinetics Inc. | Activity: Research and Development | Company Description Verinetics is commercializing platform technology that makes dispensing controlled substance pharmaceuticals safer for patients and their providers. | Location Research Triangle Park |
| |
Company Viamer Biosciences | Activity: Research and Development | Company Description Viamer Biosciences develops advanced and proprietary biomaterials for controlled release drug delivery and regenerative medical devices. | Location Durham |
| |
Company ViraTree LLC | Activity: Production and Manufacturing | Company Description ViraTree acquires, authenticates, preserves, develops and distributes virological materials, information and technology for the advancement of virus research. | Location Research Triangle Park |
| |
Company ViroKyne Therapeutics LLC | Activity: Research and Development | Company Description Virokyne is developing novel therapies for the treatment of viral diseases. | Location Durham |
| |
Company Vital Plan Inc. | Activity: Research and Development | Company Description Vital Plan formulates and produces natural supplements and herbal therapies that support immune health, microbiome balance, and healthy aging. | Location Raleigh |
| |
Company VitalEphX | Activity: Research and Development | Company Description VitalEphX develops therapeutics that preserve tissue viability and performance following myocardial infarction. | Location Greenville |
| |
Company VitriStor LLC | Activity: Research and Development | Company Description VitriStor is developing technologies to produce large quantities of hepatocytes (liver cells) on demand for cell therapy, regenerative medicine and pharmaceutical applications. | Location Charlotte |
| |
Company Vizma.AI | Activity: Research and Development | Company Description Vizma.AI provides diagnostic molecular insights to oncologists, cardiologists and neurologists with non-invasive and patient-centric technology. | Location Chapel Hill |
| |
Company Vogenx Inc. | Activity: Research and Development | Company Description Vogenx is a clinical stage pharmaceutical company developing a molecule to address post-bariatric hypoglycemia. | Location Durham |
| |
Company vTv Therapeutics LLC | Activity: Research and Development | Company Description vTv Therapeutics is a clinical-stage biopharmaceutical company developing orally administered small molecule drug candidates to fill significant unmet medical needs in Alzheimer's disease (AD), diabetes and inflammatory disorders. | Location High Point |
| |
Company Xollent Biotech Inc. | Activity: Research and Development | Company Description Xollent Biotech is developing a therapeutic to treat cardiovascular disease based on exosome-secreting cells. | Location Cary |
| |
Company Xona Microfluidics Inc. | Activity: Research and Development | Company Description Xona Microfluidics develops and manufactures microfluidic platforms for neuroscience research. | Location Research Triangle Park |
| |
Company Xsome Biotech Inc. | Activity: Research and Development | Company Description Xsome Biotech is developing inhalable vaccines using a lung-derived exosome. | Location Cary |
| |
Company Zarbio LLC | Activity: Research and Development | Company Description Zarbio develops pathophysiology-based treatments for neurodegenerative diseases such as Alzheimer's disease. | Location Chapel Hill |
| |
Company Zinfandel Pharmaceuticals Inc. | Activity: Research and Development | Company Description Zinfandel Pharmaceuticals uses pharmacogenetics to improve prediction of risk for Alzheimer’s disease and facilitate the development of effective therapies. | Location Chapel Hill |
| |
Company Zoion Pharma Inc. | Activity: Research and Development | Company Description Zoion Pharma develops drugs for veterinary disorders. Zoion's lead product is an epithelial sodium channel blocker compound to treat canine keratoconjunctivitis sicca (KCS) or dry eye. | Location Raleigh |
| |
Company ZY Therapeutics Inc. | Activity: Research and Development | Company Description ZY Therapeutics is developing a drug delivery platform for cancer therapeutics using nanotechnology. | Location Research Triangle Park |
| |
Company Zymeron Corporation | Activity: Research and Development | Company Description Zymeron develops and commercialize technologies to detect, prevent and treat infectious diseases, immune disorders and emerging pathological threats. | Location Durham |
| |
Company Zymtronix Inc. | Activity: Research and Development | Company Description Zymtronix provides technology that can enable and improve any biocatalytic reaction involving single enzymes or cell-free systems of multiple enzymes. Zymtronix offers solutions for various industries, including agriculture, life sciences, and ingredients. | Location Research Triangle Park |